Private biotechs Caldera and Vidya raise $478M collectively in reverse go-public mergers

Summary

Caldera Therapeutics and Vidya Therapeutics announced separate reverse merger deals totaling $478M collectively to go public. Both companies are advancing immunology and inflammation assets through this alternative public market entry strategy.